Global Tianeptine Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Tianeptine will have significant change from previous year. By the most conservative estimates of global Tianeptine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Tianeptine market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Tianeptine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Tianeptine, covering the supply chain analysis, impact assessment to the Tianeptine market size growth rate in several scenarios, and the measures to be undertaken by Tianeptine companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Patent
Generic
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Depression and Anxiety
Irritable Bowel Syndrome
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Servier
Glenmark
Lupin Limited
Antibiotice
Serdia Pharmaceuticals
PharmaS
Genefar B.V.
Alvogen
Arena Pharmaceuticals
Bausch Health
Neuraxpharm Arzneimittel
Grupo Insud
Novartis
Mylan
Liconsa SA
Adamed
Dongwha Pharm
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Tianeptine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Tianeptine market by identifying its various subsegments.
Focuses on the key global Tianeptine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Tianeptine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Tianeptine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Tianeptine?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Tianeptine Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tianeptine Consumption 2015-2025
2.1.2 Tianeptine Consumption CAGR by Region
2.2 Tianeptine Segment by Type
2.2.1 Patent
2.2.2 Generic
2.3 Tianeptine Consumption by Type
2.3.1 Global Tianeptine Consumption Market Share by Type (2015-2020)
2.3.2 Global Tianeptine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Tianeptine Sale Price by Type (2015-2020)
2.4 Tianeptine Segment by Application
2.4.1 Depression and Anxiety
2.4.2 Irritable Bowel Syndrome
2.5 Tianeptine Consumption by Application
2.5.1 Global Tianeptine Consumption Market Share by Type (2015-2020)
2.5.2 Global Tianeptine Value and Market Share by Type (2015-2020)
2.5.3 Global Tianeptine Sale Price by Type (2015-2020)
3 Global Tianeptine by Company
3.1 Global Tianeptine Sales Market Share by Company
3.1.1 Global Tianeptine Sales by Company (2018-2020)
3.1.2 Global Tianeptine Sales Market Share by Company (2018-2020)
3.2 Global Tianeptine Revenue Market Share by Company
3.2.1 Global Tianeptine Revenue by Company (2018-2020)
3.2.2 Global Tianeptine Revenue Market Share by Company (2018-2020)
3.3 Global Tianeptine Sale Price by Company
3.4 Global Tianeptine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Tianeptine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Tianeptine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Tianeptine by Regions
4.1 Tianeptine by Regions
4.2 Americas Tianeptine Consumption Growth
4.3 APAC Tianeptine Consumption Growth
4.4 Europe Tianeptine Consumption Growth
4.5 Middle East & Africa Tianeptine Consumption Growth
5 Americas
5.1 Americas Tianeptine Consumption by Countries
5.1.1 Americas Tianeptine Consumption by Countries (2015-2020)
5.1.2 Americas Tianeptine Value by Countries (2015-2020)
5.2 Americas Tianeptine Consumption by Type
5.3 Americas Tianeptine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Tianeptine Consumption by Regions
6.1.1 APAC Tianeptine Consumption by Regions (2015-2020)
6.1.2 APAC Tianeptine Value by Regions (2015-2020)
6.2 APAC Tianeptine Consumption by Type
6.3 APAC Tianeptine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Tianeptine by Countries
7.1.1 Europe Tianeptine Consumption by Countries (2015-2020)
7.1.2 Europe Tianeptine Value by Countries (2015-2020)
7.2 Europe Tianeptine Consumption by Type
7.3 Europe Tianeptine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Tianeptine by Countries
8.1.1 Middle East & Africa Tianeptine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Tianeptine Value by Countries (2015-2020)
8.2 Middle East & Africa Tianeptine Consumption by Type
8.3 Middle East & Africa Tianeptine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Tianeptine Distributors
10.3 Tianeptine Customer
11 Global Tianeptine Market Forecast
11.1 Global Tianeptine Consumption Forecast (2021-2025)
11.2 Global Tianeptine Forecast by Regions
11.2.1 Global Tianeptine Forecast by Regions (2021-2025)
11.2.2 Global Tianeptine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Tianeptine Forecast by Type
11.8 Global Tianeptine Forecast by Application
12 Key Players Analysis
12.1 Servier
12.1.1 Company Information
12.1.2 Tianeptine Product Offered
12.1.3 Servier Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Servier Latest Developments
12.2 Glenmark
12.2.1 Company Information
12.2.2 Tianeptine Product Offered
12.2.3 Glenmark Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Glenmark Latest Developments
12.3 Lupin Limited
12.3.1 Company Information
12.3.2 Tianeptine Product Offered
12.3.3 Lupin Limited Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Lupin Limited Latest Developments
12.4 Antibiotice
12.4.1 Company Information
12.4.2 Tianeptine Product Offered
12.4.3 Antibiotice Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Antibiotice Latest Developments
12.5 Serdia Pharmaceuticals
12.5.1 Company Information
12.5.2 Tianeptine Product Offered
12.5.3 Serdia Pharmaceuticals Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Serdia Pharmaceuticals Latest Developments
12.6 PharmaS
12.6.1 Company Information
12.6.2 Tianeptine Product Offered
12.6.3 PharmaS Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 PharmaS Latest Developments
12.7 Genefar B.V.
12.7.1 Company Information
12.7.2 Tianeptine Product Offered
12.7.3 Genefar B.V. Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Genefar B.V. Latest Developments
12.8 Alvogen
12.8.1 Company Information
12.8.2 Tianeptine Product Offered
12.8.3 Alvogen Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Alvogen Latest Developments
12.9 Arena Pharmaceuticals
12.9.1 Company Information
12.9.2 Tianeptine Product Offered
12.9.3 Arena Pharmaceuticals Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Arena Pharmaceuticals Latest Developments
12.10 Bausch Health
12.10.1 Company Information
12.10.2 Tianeptine Product Offered
12.10.3 Bausch Health Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Bausch Health Latest Developments
12.11 Neuraxpharm Arzneimittel
12.11.1 Company Information
12.11.2 Tianeptine Product Offered
12.11.3 Neuraxpharm Arzneimittel Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Neuraxpharm Arzneimittel Latest Developments
12.12 Grupo Insud
12.12.1 Company Information
12.12.2 Tianeptine Product Offered
12.12.3 Grupo Insud Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Grupo Insud Latest Developments
12.13 Novartis
12.13.1 Company Information
12.13.2 Tianeptine Product Offered
12.13.3 Novartis Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Novartis Latest Developments
12.14 Mylan
12.14.1 Company Information
12.14.2 Tianeptine Product Offered
12.14.3 Mylan Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Mylan Latest Developments
12.15 Liconsa SA
12.15.1 Company Information
12.15.2 Tianeptine Product Offered
12.15.3 Liconsa SA Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Liconsa SA Latest Developments
12.16 Adamed
12.16.1 Company Information
12.16.2 Tianeptine Product Offered
12.16.3 Adamed Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Adamed Latest Developments
12.17 Dongwha Pharm
12.17.1 Company Information
12.17.2 Tianeptine Product Offered
12.17.3 Dongwha Pharm Tianeptine Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Dongwha Pharm Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Tianeptine Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Tianeptine Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Tianeptine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Patent
Table 7. Major Players of Generic
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Tianeptine Consumption Market Share by Type (2015-2020)
Table 10. Global Tianeptine Revenue by Type (2015-2020) ($ million)
Table 11. Global Tianeptine Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Tianeptine Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Tianeptine Consumption Market Share by Application (2015-2020)
Table 15. Global Tianeptine Value by Application (2015-2020)
Table 16. Global Tianeptine Value Market Share by Application (2015-2020)
Table 17. Global Tianeptine Sale Price by Application (2015-2020)
Table 18. Global Tianeptine Sales by Company (2017-2019) (K Units)
Table 19. Global Tianeptine Sales Market Share by Company (2017-2019)
Table 20. Global Tianeptine Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Tianeptine Revenue Market Share by Company (2017-2019)
Table 22. Global Tianeptine Sale Price by Company (2017-2019)
Table 23. Global Tianeptine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Tianeptine Products Offered
Table 25. Tianeptine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Tianeptine Consumption by Regions 2015-2020 (K Units)
Table 27. Global Tianeptine Consumption Market Share by Regions 2015-2020
Table 28. Global Tianeptine Value by Regions 2015-2020 ($ Millions)
Table 29. Global Tianeptine Value Market Share by Regions 2015-2020
Table 30. Americas Tianeptine Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Tianeptine Consumption Market Share by Countries (2015-2020)
Table 32. Americas Tianeptine Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Tianeptine Value Market Share by Countries (2015-2020)
Table 34. Americas Tianeptine Consumption by Type (2015-2020) (K Units)
Table 35. Americas Tianeptine Consumption Market Share by Type (2015-2020)
Table 36. Americas Tianeptine Consumption by Application (2015-2020) (K Units)
Table 37. Americas Tianeptine Consumption Market Share by Application (2015-2020)
Table 38. APAC Tianeptine Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Tianeptine Consumption Market Share by Countries (2015-2020)
Table 40. APAC Tianeptine Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Tianeptine Value Market Share by Regions (2015-2020)
Table 42. APAC Tianeptine Consumption by Type (2015-2020) (K Units)
Table 43. APAC Tianeptine Consumption Market Share by Type (2015-2020)
Table 44. APAC Tianeptine Consumption by Application (2015-2020) (K Units)
Table 45. APAC Tianeptine Consumption Market Share by Application (2015-2020)
Table 46. Europe Tianeptine Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Tianeptine Consumption Market Share by Countries (2015-2020)
Table 48. Europe Tianeptine Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Tianeptine Value Market Share by Countries (2015-2020)
Table 50. Europe Tianeptine Consumption by Type (2015-2020) (K Units)
Table 51. Europe Tianeptine Consumption Market Share by Type (2015-2020)
Table 52. Europe Tianeptine Consumption by Application (2015-2020) (K Units)
Table 53. Europe Tianeptine Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Tianeptine Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Tianeptine Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Tianeptine Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Tianeptine Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Tianeptine Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Tianeptine Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Tianeptine Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Tianeptine Consumption Market Share by Application (2015-2020)
Table 62. Tianeptine Distributors List
Table 63. Tianeptine Customer List
Table 64. Global Tianeptine Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Tianeptine Consumption Market Forecast by Regions
Table 66. Global Tianeptine Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Tianeptine Value Market Share Forecast by Regions
Table 68. Global Tianeptine Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Tianeptine Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Tianeptine Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Tianeptine Value Market Share Forecast by Type (2021-2025)
Table 72. Global Tianeptine Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Tianeptine Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Tianeptine Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Tianeptine Value Market Share Forecast by Application (2021-2025)
Table 76. Servier Product Offered
Table 77. Servier Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Servier Main Business
Table 79. Servier Latest Developments
Table 80. Servier Basic Information, Company Total Revenue (in $ million), Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 81. Glenmark Product Offered
Table 82. Glenmark Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Glenmark Main Business
Table 84. Glenmark Latest Developments
Table 85. Glenmark Basic Information, Company Total Revenue (in $ million), Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 86. Lupin Limited Product Offered
Table 87. Lupin Limited Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Lupin Limited Main Business
Table 89. Lupin Limited Latest Developments
Table 90. Lupin Limited Basic Information, Company Total Revenue (in $ million), Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 91. Antibiotice Product Offered
Table 92. Antibiotice Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Antibiotice Main Business
Table 94. Antibiotice Latest Developments
Table 95. Antibiotice Basic Information, Company Total Revenue (in $ million), Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 96. Serdia Pharmaceuticals Product Offered
Table 97. Serdia Pharmaceuticals Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Serdia Pharmaceuticals Main Business
Table 99. Serdia Pharmaceuticals Latest Developments
Table 100. Serdia Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 101. PharmaS Product Offered
Table 102. PharmaS Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. PharmaS Main Business
Table 104. PharmaS Latest Developments
Table 105. PharmaS Basic Information, Company Total Revenue (in $ million), Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 106. Genefar B.V. Product Offered
Table 107. Genefar B.V. Basic Information, Company Total Revenue (in $ million), Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 108. Genefar B.V. Main Business
Table 109. Genefar B.V. Latest Developments
Table 110. Genefar B.V. Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Alvogen Product Offered
Table 112. Alvogen Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Alvogen Main Business
Table 114. Alvogen Latest Developments
Table 115. Alvogen Basic Information, Company Total Revenue (in $ million), Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 116. Arena Pharmaceuticals Product Offered
Table 117. Arena Pharmaceuticals Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. Arena Pharmaceuticals Main Business
Table 119. Arena Pharmaceuticals Latest Developments
Table 120. Arena Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 121. Bausch Health Product Offered
Table 122. Bausch Health Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. Bausch Health Main Business
Table 124. Bausch Health Latest Developments
Table 125. Bausch Health Basic Information, Company Total Revenue (in $ million), Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 126. Neuraxpharm Arzneimittel Product Offered
Table 127. Neuraxpharm Arzneimittel Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. Neuraxpharm Arzneimittel Main Business
Table 129. Neuraxpharm Arzneimittel Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Neuraxpharm Arzneimittel Latest Developments
Table 131. Grupo Insud Product Offered
Table 132. Grupo Insud Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 133. Grupo Insud Main Business
Table 134. Grupo Insud Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Grupo Insud Latest Developments
Table 136. Novartis Product Offered
Table 137. Novartis Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 138. Novartis Main Business
Table 139. Novartis Latest Developments
Table 140. Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. Mylan Product Offered
Table 142. Mylan Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 143. Mylan Main Business
Table 144. Mylan Latest Developments
Table 145. Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 146. Liconsa SA Product Offered
Table 147. Liconsa SA Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 148. Liconsa SA Main Business
Table 149. Liconsa SA Latest Developments
Table 150. Liconsa SA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 151. Adamed Product Offered
Table 152. Adamed Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 153. Adamed Main Business
Table 154. Adamed Latest Developments
Table 155. Adamed Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 156. Dongwha Pharm Product Offered
Table 157. Dongwha Pharm Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 158. Dongwha Pharm Main Business
Table 159. Dongwha Pharm Latest Developments
Table 160. Dongwha Pharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Tianeptine
Figure 2. Tianeptine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Tianeptine Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Tianeptine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Patent
Figure 7. Product Picture of Generic
Figure 8. Global Tianeptine Consumption Market Share by Type (2015-2020)
Figure 9. Global Tianeptine Value Market Share by Type (2015-2020)
Figure 10. Tianeptine Consumed in Depression and Anxiety
Figure 11. Global Tianeptine Market: Depression and Anxiety (2015-2020) (K Units)
Figure 12. Global Tianeptine Market: Depression and Anxiety (2015-2020) ($ Millions)
Figure 13. Tianeptine Consumed in Irritable Bowel Syndrome
Figure 14. Global Tianeptine Market: Irritable Bowel Syndrome (2015-2020) (K Units)
Figure 15. Global Tianeptine Market: Irritable Bowel Syndrome (2015-2020) ($ Millions)
Figure 16. Global Tianeptine Consumption Market Share by Application (2015-2020)
Figure 17. Global Tianeptine Value Market Share by Application (2015-2020)
Figure 18. Global Tianeptine Sales Market Share by Company in 2017
Figure 19. Global Tianeptine Sales Market Share by Company in 2019
Figure 20. Global Tianeptine Revenue Market Share by Company in 2017
Figure 21. Global Tianeptine Revenue Market Share by Company in 2019
Figure 22. Global Tianeptine Sale Price by Company in 2019
Figure 23. Global Tianeptine Consumption Market Share by Regions 2015-2020
Figure 24. Global Tianeptine Value Market Share by Regions 2015-2020
Figure 25. Americas Tianeptine Consumption 2015-2020 (K Units)
Figure 26. Americas Tianeptine Value 2015-2020 ($ Millions)
Figure 27. APAC Tianeptine Consumption 2015-2020 (K Units)
Figure 28. APAC Tianeptine Value 2015-2020 ($ Millions)
Figure 29. Europe Tianeptine Consumption 2015-2020 (K Units)
Figure 30. Europe Tianeptine Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Tianeptine Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Tianeptine Value 2015-2020 ($ Millions)
Figure 33. Americas Tianeptine Consumption Market Share by Countries in 2019
Figure 34. Americas Tianeptine Value Market Share by Countries in 2019
Figure 35. Americas Tianeptine Consumption Market Share by Type in 2019
Figure 36. Americas Tianeptine Consumption Market Share by Application in 2019
Figure 37. United States Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 38. United States Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Tianeptine Consumption Market Share by Countries in 2019
Figure 44. APAC Tianeptine Value Market Share by Regions in 2019
Figure 45. APAC Tianeptine Consumption Market Share by Type in 2019
Figure 46. APAC Tianeptine Consumption Market Share by Application in 2019
Figure 47. China Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 48. China Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 55. India Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 56. India Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Tianeptine Consumption Market Share by Countries in 2019
Figure 60. Europe Tianeptine Value Market Share by Countries in 2019
Figure 61. Europe Tianeptine Consumption Market Share by Type in 2019
Figure 62. Europe Tianeptine Consumption Market Share by Application in 2019
Figure 63. Germany Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 65. France Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 66. France Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 67. UK Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 68. UK Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Tianeptine Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Tianeptine Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Tianeptine Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Tianeptine Consumption Market Share by Application in 2019
Figure 77. Egypt Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Tianeptine Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Tianeptine Value Growth 2015-2020 ($ Millions)
Figure 87. Global Tianeptine Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Tianeptine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Tianeptine Consumption 2021-2025 (K Units)
Figure 90. Americas Tianeptine Value 2021-2025 ($ Millions)
Figure 91. APAC Tianeptine Consumption 2021-2025 (K Units)
Figure 92. APAC Tianeptine Value 2021-2025 ($ Millions)
Figure 93. Europe Tianeptine Consumption 2021-2025 (K Units)
Figure 94. Europe Tianeptine Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Tianeptine Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Tianeptine Value 2021-2025 ($ Millions)
Figure 97. United States Tianeptine Consumption 2021-2025 (K Units)
Figure 98. United States Tianeptine Value 2021-2025 ($ Millions)
Figure 99. Canada Tianeptine Consumption 2021-2025 (K Units)
Figure 100. Canada Tianeptine Value 2021-2025 ($ Millions)
Figure 101. Mexico Tianeptine Consumption 2021-2025 (K Units)
Figure 102. Mexico Tianeptine Value 2021-2025 ($ Millions)
Figure 103. Brazil Tianeptine Consumption 2021-2025 (K Units)
Figure 104. Brazil Tianeptine Value 2021-2025 ($ Millions)
Figure 105. China Tianeptine Consumption 2021-2025 (K Units)
Figure 106. China Tianeptine Value 2021-2025 ($ Millions)
Figure 107. Japan Tianeptine Consumption 2021-2025 (K Units)
Figure 108. Japan Tianeptine Value 2021-2025 ($ Millions)
Figure 109. Korea Tianeptine Consumption 2021-2025 (K Units)
Figure 110. Korea Tianeptine Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Tianeptine Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Tianeptine Value 2021-2025 ($ Millions)
Figure 113. India Tianeptine Consumption 2021-2025 (K Units)
Figure 114. India Tianeptine Value 2021-2025 ($ Millions)
Figure 115. Australia Tianeptine Consumption 2021-2025 (K Units)
Figure 116. Australia Tianeptine Value 2021-2025 ($ Millions)
Figure 117. Germany Tianeptine Consumption 2021-2025 (K Units)
Figure 118. Germany Tianeptine Value 2021-2025 ($ Millions)
Figure 119. France Tianeptine Consumption 2021-2025 (K Units)
Figure 120. France Tianeptine Value 2021-2025 ($ Millions)
Figure 121. UK Tianeptine Consumption 2021-2025 (K Units)
Figure 122. UK Tianeptine Value 2021-2025 ($ Millions)
Figure 123. Italy Tianeptine Consumption 2021-2025 (K Units)
Figure 124. Italy Tianeptine Value 2021-2025 ($ Millions)
Figure 125. Russia Tianeptine Consumption 2021-2025 (K Units)
Figure 126. Russia Tianeptine Value 2021-2025 ($ Millions)
Figure 127. Spain Tianeptine Consumption 2021-2025 (K Units)
Figure 128. Spain Tianeptine Value 2021-2025 ($ Millions)
Figure 129. Egypt Tianeptine Consumption 2021-2025 (K Units)
Figure 130. Egypt Tianeptine Value 2021-2025 ($ Millions)
Figure 131. South Africa Tianeptine Consumption 2021-2025 (K Units)
Figure 132. South Africa Tianeptine Value 2021-2025 ($ Millions)
Figure 133. Israel Tianeptine Consumption 2021-2025 (K Units)
Figure 134. Israel Tianeptine Value 2021-2025 ($ Millions)
Figure 135. Turkey Tianeptine Consumption 2021-2025 (K Units)
Figure 136. Turkey Tianeptine Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Tianeptine Consumption 2021-2025 (K Units)
Figure 138. GCC Countries Tianeptine Value 2021-2025 ($ Millions)
Figure 139. Servier Tianeptine Market Share (2018-2020)
Figure 140. Glenmark Tianeptine Market Share (2018-2020)
Figure 141. Lupin Limited Tianeptine Market Share (2018-2020)
Figure 142. Antibiotice Tianeptine Market Share (2018-2020)
Figure 143. Serdia Pharmaceuticals Tianeptine Market Share (2018-2020)
Figure 144. PharmaS Tianeptine Market Share (2018-2020)
Figure 145. Genefar B.V. Tianeptine Market Share (2018-2020)
Figure 146. Alvogen Tianeptine Market Share (2018-2020)
Figure 147. Arena Pharmaceuticals Tianeptine Market Share (2018-2020)
Figure 148. Bausch Health Tianeptine Market Share (2018-2020)
Figure 149. Neuraxpharm Arzneimittel Tianeptine Market Share (2018-2020)
Figure 150. Grupo Insud Tianeptine Market Share (2018-2020)
Figure 151. Novartis Tianeptine Market Share (2018-2020)
Figure 152. Mylan Tianeptine Market Share (2018-2020)
Figure 153. Liconsa SA Tianeptine Market Share (2018-2020)
Figure 154. Adamed Tianeptine Market Share (2018-2020)
Figure 155. Dongwha Pharm Tianeptine Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets